Mild Cognitive Impairment Associated with Obstructive Sleep Apnoea: A Pilot Study on Oxygen-Related Plasma Biomarkers and Network Analysis
Authors:
- Martina De FeliceMFMartina De Felice
- Alessia PascazioAPAlessia Pascazio
- Rebecca PiccarducciRPRebecca Piccarducci
- Lorenzo GermelliLorenzo Germelli
- Martina CirincianiMCMartina Cirinciani
- Jonathan FusiJFJonathan Fusi
- Simona CintoliSCSimona Cintoli
- Maria Letizia TrincavelliMTMaria Letizia Trincavelli
- Ferdinando FranzoniFerdinando Franzoni
- Filippo BaldacciFBFilippo Baldacci
- Paolo MilazzoPMPaolo Milazzo
- 1 January 2026
- journal article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1)
Abstract
Obstructive sleep apnoea syndrome (OSAS) is a breathing disorder frequently associated with mild cognitive impairment (MCI), a potential prodromal stage of Alzheimer's disease (AD). However, the mechanisms underlying MCI in OSAS remain unclear, making the identification of early biomarkers crucial. This pilot study investigates biochemical parameters related to oxygen disturbance and AD in OSAS patients with and without MCI (OSAS + MCI and OSAS-MCI, respectively) and explores their interplay through a network-based analysis. A total of 45 subjects (30 OSAS patients; 15 healthy controls) were enrolled, undergoing clinical assessment, polygraphy, and blood sampling. Compared to controls, OSAS patients exhibited increased apnoea-hypopnea index, oxygen desaturation index, and the percentage of cumulative time with oxygen saturation below 90% during total sleep time (T90). Notably, in the entire OSAS cohort, T90 positively correlated with HIF-1α levels, which were higher than controls, although not significantly. Interestingly, both T90 and HIF-1α were elevated in OSAS + MCI patients compared to OSAS-MCI, confirming a positive correlation between their levels. Regarding AD-related biomarkers, t-Tau and p-Tau181 levels were elevated in OSAS + MCI. AUROC analysis demonstrated that HIF-1α and t-Tau had fair discriminative ability, whereas p-Tau181 showed good differentiation between OSAS + MCI and OSAS-MCI. Finally, a network-based analysis suggested HIF-1α as possible candidate player in disease pathways, potentially interacting with Tau phosphorylation via GSK-3β. These findings recommend HIF-1α, t-Tau, and p-Tau181 as possible peripheral candidates for early MCI detection in OSAS, pointing out their possible involvement in the pathogenesis of cognitive impairment in OSAS pathology.Keywords
This publication has 118 references indexed in Scilit:
- Plasma expression of HIF‐1α as novel biomarker for the diagnosis of obstructive sleep apnea‐hypopnea syndromeJournal of Clinical Laboratory Analysis, 2020
- Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission TomographyJAMA Neurology, 2020
- Association of Sleep-Disordered Breathing With Cognitive Function and Risk of Cognitive ImpairmentJAMA Neurology, 2017
- The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence AnalysesCurrent Protocols in Bioinformatics, 2016
- Obstructive sleep apnea decreases central nervous system–derived proteins in the cerebrospinal fluidAnnals of Neurology, 2016
- Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's diseaseHuman Brain Mapping, 2013
- Negative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxiaJournal of Cellular Biochemistry, 2011
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- MAPK and Akt Act Cooperatively but Independently on Hypoxia Inducible Factor-1α in rasV12 Upregulation of VEGFBiochemical and Biophysical Research Communications, 2001
- Mild Cognitive ImpairmentArchives of Neurology, 1999